close
13M Shelter Meals Donated 143K Toys Donated $284K Funded for Service Dogs $30K Disaster Relief Funds Raised 163K Rescue Miles Funded

URGENT RECALL: Phenobarbital Recalled By Manufacturer After Mislabeling Issue

Phenobarbital manufacturer C.O. Truxton, Inc. has voluntarily recalled a certain lot of its medication due to a mislabeling error. They received a confirmed customer complaint that bottles of their 15mg tablets are containing 30mg tablets, which poses a very serious overdose risk to patients exposed to the mislabeled drugs. All pet owners giving their dogs the anti-seizure, anti-convulsant drug phenobarbital are encouraged to check their medications immediately.

They are recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg. According to The Doginton Post, “The product is indicated for use as a sedative or anticonvulsant and is packaged in 1000 count bottles, NDC 0463-6160-10, UPC 7 0463616010 6, lot number 70952A, expiration date 11/17. The 15 mg Tablet is debossed with ‘West-ward 445’ on one side and blank on the reverse side; the 30 mg Tablet is debossed with ‘West-ward 450’ on one side and scored on the reverse side.”

Image source: Simon D | Flickr

These phenobarbital tablets were distributed to physician and veterinarian treatment centers across the United States. According to the FDA, “C.O. Truxton, Inc. is notifying all customers on record who purchased the affected product via US Mail which includes a recall letter, recall response form and is arranging for full credit returns, replacements, etc. of all recalled product. Consumers/distributors/retailers that have recalled product should stop using the product and return their product to their place of purchase.” C.O. Truxton, Inc. can be contacted by phone at (856) 933-2333, Monday to Friday between the hours of 9am and 5pm (EST). Anyone with 15mg phenobarbital tablets is encouraged to seek veterinary advice right away.

Do you want a healthier & happier dog? Join our email list & we'll donate 1 meal to a shelter dog in need!

Written by Katie Finlay
Story Page